EP2458992
Meðferð við Crohns sjúkdómi með laquinimod
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
29.7.2010EP published:
16.12.2015EP application number:
10804826.5
EP translation filed:
12.2.2016Grant published:
15.3.2016EPO information:
European Patent Register
Max expiry date:
28.7.2030Expiry date:
28.7.2018
Title:
TREATMENT OF CROHN'S DISEASE WITH LAQUINIMOD
Timeline
Today
29.7.2010EP application
16.12.2015EP Publication
12.2.2016Translation submitted
15.3.2016Registration published
28.7.2018Expires
Owner
Name:
Teva Pharmaceutical Industries Ltd.Address:
5 Basel Street P.O. Box 3190, 49131, Petach-Tikva, IL
Inventor
Name:
TARCIC, NoraAddress:
Modlin, IL
Name:
HAVIV, AsiAddress:
(Gan Shlomo), IL
Name:
BLAUGRUND, EranAddress:
Rehovot, IL
Name:
KAYE, JoelAddress:
Netanya, IL
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
273167 PDate:
30.7.2009Country:
US
Classification
Categories:
A61K 31/4704, A61K 31/42, A01N 43/42, A61P 1/00, A61K 31/573, A61K 31/606, A61K 31/58, A61K 45/06, C07D 215/56
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.6.2016
Expires: 28.7.2017
Payer: G. H. Sigurgeirsson
Number: 8
Paid: 20.6.2017
Expires: 28.7.2018
Payer: G. H. Sigurgeirsson